Ana Luzarraga Aznar

12PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Obstetrics and gynaecologySurgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 10, 2026
Postvoid Residual Volume After Radical Hysterectomy for Early-Stage Cervical Cancer: Predictive Factors and a Decision-Making Algorithm.

Naia Seminario, Vicente Bebia, Ana Luzarraga Aznar

|Sep 07, 2024
Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al.

Ana Luzarraga Aznar, Vicente Bebia, Silvia Cabrera

|Aug 23, 2024
Advanced cytoreductive procedures: patient positioning and exposition maneuvers in 10 steps.

Ana Luzarraga Aznar, Vicente Bebia, Ursula Acosta

|Aug 17, 2024
SENECA study: staging endometrial cancer based on molecular classification.

Enrique Chacon, Felix Boria, R Rajagopalan Lyer

|Aug 08, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy.

Violeta Romero, Martina Aida Angeles, Elena Rodríguez González

|Apr 10, 2024
Response to: Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Zhang and Sun.

Vicente Bebia, Ana Luzarraga Aznar, Silvia Cabrera

Pageof 2

Frequent Collaborators

5 joint publications

Vicente Bebia

4 joint publications

Silvia Cabrera

4 joint publications

Martina Aida Angeles

2 joint publications

Gwénaël Ferron